References
- Hartzema AG. Pharmacoepidemiology—its relevance to clinical practice. J Clin Pharm Ther 1992; 17: 73–4
- Tohen M, Castillo J, Baldessarini RJ, Kando J. The course of leukopenia caused by anticonvulsants. Presented at the 145th annual meeting of the American Psychiatric Association, Washington, DC, May, 2–71992
- Platt R, Stryker WS, Komaroff AL. Pharmacoepidemiology in hospitals using automated data systems. Am J Prev Med 1988; 4(suppl 2)39–47
- Avorn J, Everitt DE, Weiss S. Increased antidepressant use in patients prescribed beta-blockers. JAMA 1986; 255: 357–60
- Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton JL. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987; 316: 363–9
- Hoffman RP. Adverse drug reactions revisited—JCAHO. Hosp Pharm 1988; 23: 685–7
- Tilson HH. Pharmacoepidemiology: the lessons learned; the challenges ahead [Letter]. Clin Pharmacol Ther 1989; 46: 480
- Tohen M, Castillo J, Pope HG, Herbstein J. Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders. J Clin Psychopharmacol 1994; 14: 9–15
- Tilson HH. Pharmacoepidemiology: the future. Drug Intel Clin Pharm 1988; 22: 416–21